{
  "url": "https://openlegislation.uk/nicotine-inhaling-products-age-of-sale-and-proxy-purchasing-regulations-2015/regulation-5",
  "json_url": "https://openlegislation.uk/nicotine-inhaling-products-age-of-sale-and-proxy-purchasing-regulations-2015/regulation-5.json",
  "legislation": "uksi/2015/895",
  "legislation_title": "The Nicotine Inhaling Products (Age of Sale and Proxy Purchasing) Regulations 2015",
  "legislation_url": "https://openlegislation.uk/nicotine-inhaling-products-age-of-sale-and-proxy-purchasing-regulations-2015",
  "path": "regulation/5",
  "kind": "regulation",
  "number": "5",
  "heading": "Exception for medicines indicated for the treatment of persons aged under 18",
  "text": "(1) This regulation applies to the sale of a nicotine inhaling product which—\n(a) is an authorised medicinal product; and\n(b) is indicated for the treatment of persons of the age of the person to whom the product is sold.\n(2) For the purposes of this regulation—\n(a) a product is indicated for the treatment of persons of a particular age if it is described as such in the summary of the product characteristics for the product in accordance with paragraph 27 of Schedule 8 to the Human Medicines Regulations 2012 (summary of the product characteristics) ...;\n(b) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .\n(c) a medicinal product is “authorised” if one of the following is in force for the product—\n(i) a UK marketing authorisation; or\n(ii) a parallel import licence.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in reg. 5(2)(a) omitted (31.12.2020) by virtue of The Tobacco Products and Nicotine Inhaling Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/41), regs. 1, 5(2)(a); 2020 c. 1, Sch. 5 para. 1(1)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Reg. 5(2)(b) omitted (31.12.2020) by virtue of The Tobacco Products and Nicotine Inhaling Products (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/41), regs. 1, 5(2)(b); 2020 c. 1, Sch. 5 para. 1(1)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Word in reg. 5(2)(c)(i) inserted (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), reg. 1, Sch. 8 para. 13(3); 2020 c. 1, Sch. 5 para. 1(1)"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2015/895/regulation/5",
    "retrieved_at": "2026-10-28T23:40:14.205711+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}